Cargando…
Clinical effects of antiplatelet drugs and statins on D‐dimer levels
BACKGROUND: Acute pulmonary embolism may be ruled out by combining nonhigh clinical probability and a normal D‐dimer level. Both antiplatelet drugs and HMG‐CoA reductase inhibitors (statins) have been associated with effects on thrombus formation, potentially influencing D‐dimer levels in this setti...
Autores principales: | Schol‐Gelok, Suzanne, van der Hulle, Tom, Biedermann, Joseph S., van Gelder, Teun, Klok, Frederikus A., van der Pol, Liselotte M., Versmissen, Jorie, Huisman, Menno V., Kruip, Marieke J. H. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055760/ https://www.ncbi.nlm.nih.gov/pubmed/29682728 http://dx.doi.org/10.1111/eci.12944 |
Ejemplares similares
-
Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2020) -
Chest X-Ray Not Routinely Indicated Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism
por: van der Pol, Liselotte M., et al.
Publicado: (2019) -
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018) -
Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Klok, Frederikus A., et al.
Publicado: (2019) -
A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency
por: Atiq, Ferdows, et al.
Publicado: (2015)